BDX vs. ABT, ISRG, BSX, SYK, MDT, EW, IDXX, RMD, DXCM, and STE
Should you be buying Becton, Dickinson and Company stock or one of its competitors? The main competitors of Becton, Dickinson and Company include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Becton, Dickinson and Company vs.
Abbott Laboratories (NYSE:ABT) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
Abbott Laboratories has higher revenue and earnings than Becton, Dickinson and Company. Abbott Laboratories is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories presently has a consensus target price of $142.59, suggesting a potential upside of 7.27%. Becton, Dickinson and Company has a consensus target price of $235.88, suggesting a potential upside of 39.89%. Given Becton, Dickinson and Company's higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Abbott Laboratories.
In the previous week, Becton, Dickinson and Company had 7 more articles in the media than Abbott Laboratories. MarketBeat recorded 54 mentions for Becton, Dickinson and Company and 47 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.14 beat Becton, Dickinson and Company's score of 0.45 indicating that Abbott Laboratories is being referred to more favorably in the media.
Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.8%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.5%. Abbott Laboratories pays out 30.6% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Abbott Laboratories has raised its dividend for 54 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years.
Abbott Laboratories has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500.
Abbott Laboratories received 347 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 70.00% of users gave Abbott Laboratories an outperform vote while only 62.05% of users gave Becton, Dickinson and Company an outperform vote.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Abbott Laboratories has a net margin of 31.95% compared to Becton, Dickinson and Company's net margin of 8.47%. Abbott Laboratories' return on equity of 20.74% beat Becton, Dickinson and Company's return on equity.
Summary
Abbott Laboratories beats Becton, Dickinson and Company on 17 of the 22 factors compared between the two stocks.
Get Becton, Dickinson and Company News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Becton, Dickinson and Company Competitors List
Related Companies and Tools
This page (NYSE:BDX) was last updated on 5/3/2025 by MarketBeat.com Staff
Buy BDX Stock Free BDX Stock Alerts